Pathological analysis of mastitis mouse models provides the histological and molecular evidence required to characterize mammary gland inflammation and evaluate therapeutic efficacy in preclinical studies. This technical article outlines the principal model types, sample requirements, testing items, analytical methods, and typical applications for laboratories conducting mastitis model evaluation in accordance with recognized quality standards.
Technical Overview
Mastitis is defined as inflammation of the mammary gland, most frequently caused by bacterial infection or endotoxin exposure during lactation. Mouse models of mastitis are widely used in preclinical research to reproduce key features of the human and bovine disease, including neutrophil infiltration, alveolar damage, disruption of the blood–milk barrier, and elevated pro-inflammatory mediators. Pathological analysis of these models constitutes the core evidence package for pharmacodynamic studies, mechanism research, and safety evaluation of anti-mastitis therapeutic candidates.
The most commonly established model types include:
- LPS-induced mastitis: intramammary injection of Escherichia coli lipopolysaccharide (LPS) via the teat canal, typically 25–100 µg per gland in lactating mice.
- Staphylococcus aureus-induced mastitis: intraductal inoculation of viable S. aureus suspensions (approximately 100–1000 CFU per gland) to mimic contagious mastitis.
- Streptococcus agalactiae and Streptococcus uberis models: used for streptococcal mastitis pathogenesis and vaccine research.
- Sterile inflammation models: sodium caseinate or carrageenan administration for non-infectious inflammation studies.
Pathological evaluation endpoints typically combine gross lesion observation, histopathology, inflammatory mediator quantification, oxidative stress markers, and microbial burden determination. Studies should be designed and reported in accordance with the ARRIVE guidelines and performed in facilities compliant with applicable laboratory animal standards such as GB 14925 or equivalent national requirements.
Testing Samples
Mammary Gland Tissue
The fourth (inguinal) and fifth abdominal mammary glands are the standard collection sites. Tissues may be fixed in 10% neutral buffered formalin for paraffin embedding, snap-frozen in liquid nitrogen for protein analysis, or preserved in RNAlater for gene expression testing.
Serum and Plasma
Peripheral blood collected via retro-orbital puncture, submandibular vein, or terminal cardiac puncture is used for systemic cytokine measurement, serum biochemistry, and complete blood count analysis.
Tissue Homogenates
Mammary gland homogenates prepared in sterile PBS or protein lysis buffer provide material for myeloperoxidase (MPO) activity assays, cytokine ELISA, and Western blot analysis.
Other Biological Specimens
Milk samples, mammary lymph nodes, spleen, liver, and lung tissue may be collected to assess systemic dissemination, immune organ response, and distant organ injury.
Testing Items
A comprehensive pathological analysis panel for mastitis mouse models generally covers the following categories:
Histopathological Evaluation
- Hematoxylin and eosin (H&E) staining of mammary gland sections.
- Semi-quantitative histopathological scoring of alveolar structure, inflammatory cell infiltration, interstitial edema, necrosis, and desquamation of mammary epithelial cells.
- Mammary gland injury grading on a 0–4 scale with blinded scoring performed independently by two veterinary pathologists.
Inflammation Markers
- Pro-inflammatory cytokines: TNF-α, IL-1β, IL-6, IL-18.
- Anti-inflammatory cytokines: IL-10, TGF-β.
- Chemokines: CXCL1 (KC), MCP-1 (CCL2).
- Myeloperoxidase (MPO) activity as a surrogate indicator of neutrophil infiltration.
- Acute phase proteins: serum amyloid A (SAA) and C-reactive protein (CRP).
Signaling Pathway Proteins
- NF-κB pathway: p65 phosphorylation and nuclear translocation, IκBα degradation.
- MAPK pathway: phosphorylated p38, ERK1/2, and JNK.
- NLRP3 inflammasome components: NLRP3, ASC, caspase-1.
- Toll-like receptor 4 (TLR4) expression.
Barrier and Tight Junction Markers
- ZO-1, occludin, and claudin family proteins evaluated by immunohistochemistry, immunofluorescence, or Western blot.
Oxidative Stress Markers
- Malondialdehyde (MDA) concentration.
- Superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px) activities.
- Reactive oxygen species (ROS) levels.
Microbiological Burden
- Bacterial colony-forming unit (CFU) enumeration from mammary tissue homogenates.
- Gram staining and bacterial identification from infected glands.
Apoptosis and Cell Damage
- TUNEL assay for apoptotic mammary epithelial cells.
- Caspase-3, Bax, and Bcl-2 expression analysis.
Testing Methods
Histopathology (H&E Staining)
Fixed mammary glands are paraffin embedded, sectioned at 3–5 µm, and stained with hematoxylin and eosin. Sections are examined by light microscopy for alveolar epithelial damage, inflammatory cell infiltration (predominantly neutrophils), interstitial edema, and disruption of acinar architecture.
Immunohistochemistry (IHC) and Immunofluorescence (IF)
IHC localizes target proteins such as p-p65, ZO-1, occludin, and F4/80 in tissue sections, while IF enables co-localization of tight junction proteins along the mammary epithelium and quantification of positive staining area using calibrated image analysis software.
ELISA
Sandwich ELISA kits quantify TNF-α, IL-1β, IL-6, and IL-10 concentrations in serum and tissue homogenates against validated standard curves.
qRT-PCR
Total RNA extracted from mammary tissue is reverse transcribed and amplified using SYBR Green chemistry; mRNA expression of cytokines and pathway genes is normalized to β-actin or GAPDH and calculated using the 2-ΔΔCt method.
Western Blot
Protein lysates are separated by SDS-PAGE, transferred to PVDF membranes, and probed with specific antibodies against pathway proteins to determine expression levels and phosphorylation status.
CFU Enumeration
Serial dilutions of gland homogenates are plated on blood agar or mannitol salt agar and incubated aerobically at 37 °C for 24 hours before colony counting to quantify residual bacterial load.
Biochemical and Enzymatic Assays
Colorimetric or fluorometric assay kits are used for MPO activity, MDA, SOD, CAT, and GSH-Px determination in tissue homogenates.
Applications
- Efficacy evaluation of anti-inflammatory drugs, botanical extracts, and natural products against LPS- or bacteria-induced mastitis.
- Preclinical screening of antibiotics, antimicrobial peptides, nanoparticle formulations, and probiotics.
- Mechanistic investigation of inflammatory signaling pathways (TLR4/NF-κB, MAPK, NLRP3) in mammary gland injury.
- Vaccine and immunomodulatory therapy development against staphylococcal and streptococcal mastitis.
- Study of blood–milk barrier integrity and lactation physiology under inflammatory stress.
- Generation of data packages in accredited third-party laboratories and GLP-compliant facilities in support of regulatory submissions.
FAQ
How is a mastitis mouse model established?
Lactating mice (typically C57BL/6 or BALB/c, days 10–14 of lactation) are anesthetized, the teat canal of the fourth mammary gland is gently cannulated, and an LPS solution or bacterial suspension is injected intraductally in a small volume. The contralateral gland receiving sterile PBS serves as the negative control.
What is the typical observation period?
For LPS-induced models, pathological endpoints are usually assessed 12–48 hours after challenge. For S. aureus models, observation may extend to 48–72 hours or longer depending on the study design and therapeutic intervention schedule.
What histopathological scoring criteria are applied?
Scoring commonly grades alveolar epithelial degeneration, neutrophil infiltration density, interstitial edema, necrosis, and hemorrhage on a 0–4 scale (0 = normal; 4 = severe diffuse damage), with mean scores calculated from multiple high-power fields per section by blinded pathologists.
Which mouse strains are commonly used?
C57BL/6 and BALB/c mice are the most frequently used strains; the choice depends on the pathogen, immune endpoint of interest, and compatibility with gene-deficient lines for mechanistic studies.
Can these analyses be performed in an accredited laboratory?
Yes. Histology, immunostaining, ELISA, qPCR, Western blot, and CFU assays can be performed in accredited third-party laboratories operating under ISO/IEC 17025-aligned quality management systems, ensuring traceable and reproducible data.